Matches in Wikidata for { <http://www.wikidata.org/entity/Q90428589> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- Q90428589 description "article scientifique publié en 2019" @default.
- Q90428589 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q90428589 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90428589 description "scientific article published on 01 July 2019" @default.
- Q90428589 description "wetenschappelijk artikel" @default.
- Q90428589 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q90428589 name "Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain" @default.
- Q90428589 name "Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain" @default.
- Q90428589 type Item @default.
- Q90428589 label "Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain" @default.
- Q90428589 label "Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain" @default.
- Q90428589 prefLabel "Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain" @default.
- Q90428589 prefLabel "Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain" @default.
- Q90428589 P1433 Q90428589-566B21E3-B890-41EE-96C3-E893D9DD18D1 @default.
- Q90428589 P1476 Q90428589-856357B1-675C-4D5A-A5AF-09992A4365EF @default.
- Q90428589 P2093 Q90428589-05688F5A-055B-413B-8A14-25738D62A7A2 @default.
- Q90428589 P2093 Q90428589-4EE7C5FB-5F0E-4F9E-A5C1-40054DB4C1E8 @default.
- Q90428589 P2093 Q90428589-71AA7931-6FB7-49C2-9AB0-66E2D548CB2D @default.
- Q90428589 P2860 Q90428589-0935BE59-1E96-4CB9-BEA3-2DA688816408 @default.
- Q90428589 P2860 Q90428589-108AFA7C-0B9A-45EF-9756-E05D149BDBAB @default.
- Q90428589 P2860 Q90428589-12D8BFC0-0FFF-44DD-BF53-8498FE6D96F1 @default.
- Q90428589 P2860 Q90428589-14C96621-13BF-49C4-B319-0762521541F3 @default.
- Q90428589 P2860 Q90428589-2B9182A4-06D7-4E90-8197-4427B1027775 @default.
- Q90428589 P2860 Q90428589-38BBAC3A-3E1A-4507-86B3-4DA06811D42E @default.
- Q90428589 P2860 Q90428589-45BE2624-65B7-4A88-9332-0C1951D440AA @default.
- Q90428589 P2860 Q90428589-48174396-D26A-4EC9-9DF0-12FEAEEE3A5C @default.
- Q90428589 P2860 Q90428589-50653E02-9801-495C-BAD8-4C98BA2A8E68 @default.
- Q90428589 P2860 Q90428589-569C8BF3-37E2-4F37-92CA-96DC5DA7710E @default.
- Q90428589 P2860 Q90428589-67867C28-1F7F-4151-92CF-ABF8046383DC @default.
- Q90428589 P2860 Q90428589-6CC07ECB-7195-440D-B676-15AE5E266759 @default.
- Q90428589 P2860 Q90428589-6DF1CD36-04EA-499D-9959-CE4E4226134A @default.
- Q90428589 P2860 Q90428589-727362EB-1E43-4A2E-B95F-C14FA0BD5186 @default.
- Q90428589 P2860 Q90428589-79039686-A184-4621-A284-4B5A22BCD671 @default.
- Q90428589 P2860 Q90428589-95418E9F-C17E-41C1-8A70-973A85F3577C @default.
- Q90428589 P2860 Q90428589-A134BD61-33AC-4CB2-AFAC-FADB3959BBD3 @default.
- Q90428589 P2860 Q90428589-A77575C3-4D99-41C1-AD52-B27BC7808576 @default.
- Q90428589 P2860 Q90428589-C18C4B24-127B-4C81-B678-BE5D872506E9 @default.
- Q90428589 P2860 Q90428589-C20A42B1-9D52-49F1-A2CF-70CFB85B2E55 @default.
- Q90428589 P2860 Q90428589-C5C12044-8022-4E4F-B80D-70354DAC224F @default.
- Q90428589 P2860 Q90428589-E58DB39A-9021-4D7A-BC5D-40EFD8E767F3 @default.
- Q90428589 P304 Q90428589-2C7A7693-DBB4-4957-A545-3BCDDA050587 @default.
- Q90428589 P31 Q90428589-8C670C02-5D9C-4CF6-9416-5C61432CF1D7 @default.
- Q90428589 P31 Q90428589-eee84b18-1e15-479a-9333-d9f283b11f3f @default.
- Q90428589 P356 Q90428589-3BFEA70F-D0A1-4A46-BD52-3FDC9E8BBEA1 @default.
- Q90428589 P433 Q90428589-E80D6AC4-DDA0-48D3-B812-C56D3532EAA6 @default.
- Q90428589 P478 Q90428589-290392DE-4D85-4569-884A-53BBBDC81A92 @default.
- Q90428589 P577 Q90428589-A7349991-4B17-4E48-9831-14D932BDA3FD @default.
- Q90428589 P698 Q90428589-78CF7CDC-9463-4F4D-8F17-71F9E27D548D @default.
- Q90428589 P921 Q90428589-46A32422-01CC-4575-894F-6BAB1077319E @default.
- Q90428589 P932 Q90428589-206930CB-4E83-42B1-9510-BA4565C1B579 @default.
- Q90428589 P356 ATM.2019.05.72 @default.
- Q90428589 P698 31576334 @default.
- Q90428589 P1433 Q26842362 @default.
- Q90428589 P1476 "Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain" @default.
- Q90428589 P2093 "D Ross Camidge" @default.
- Q90428589 P2093 "Dexiang Gao" @default.
- Q90428589 P2093 "Jose M Pacheco" @default.
- Q90428589 P2860 Q28314934 @default.
- Q90428589 P2860 Q29615476 @default.
- Q90428589 P2860 Q29620301 @default.
- Q90428589 P2860 Q29620902 @default.
- Q90428589 P2860 Q29620913 @default.
- Q90428589 P2860 Q33909900 @default.
- Q90428589 P2860 Q37637845 @default.
- Q90428589 P2860 Q38975751 @default.
- Q90428589 P2860 Q39135152 @default.
- Q90428589 P2860 Q39388286 @default.
- Q90428589 P2860 Q40163779 @default.
- Q90428589 P2860 Q40408396 @default.
- Q90428589 P2860 Q41112103 @default.
- Q90428589 P2860 Q47450132 @default.
- Q90428589 P2860 Q48794903 @default.
- Q90428589 P2860 Q52586557 @default.
- Q90428589 P2860 Q57069963 @default.
- Q90428589 P2860 Q64102469 @default.
- Q90428589 P2860 Q90836575 @default.
- Q90428589 P2860 Q90942820 @default.
- Q90428589 P2860 Q91341294 @default.
- Q90428589 P2860 Q92905904 @default.
- Q90428589 P304 "S127" @default.
- Q90428589 P31 Q13442814 @default.
- Q90428589 P31 Q871232 @default.
- Q90428589 P356 "10.21037/ATM.2019.05.72" @default.
- Q90428589 P433 "Suppl 3" @default.
- Q90428589 P478 "7" @default.
- Q90428589 P577 "2019-07-01T00:00:00Z" @default.
- Q90428589 P698 "31576334" @default.
- Q90428589 P921 Q13896859 @default.
- Q90428589 P932 "6685853" @default.